778518 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry? |
2021-12-01 |
10.1016/j.ihj.2021.11.185 |
Reddy Lakshmi Lavanya, Shah Swarup A.V., Ashavaid Tester F. |
778517 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
(Rose Bengal)/(Eosin Yellow)-Gold-Polypyrrole Hybrids: A Design for Dual Photo-Active Nano-System with Ultra-High Loading Capacity |
2021-12-01 |
10.2147/dddt.s338922 |
El-Kholy Abdullah I, Abdel Fadeel Doaa, Nasr Maha, Fadel Maha, El-Sherbiny Ibrahim |
778516 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Pro-Angiogenic Effects of Essential Oil from Perilla frutescens and Its Main Component (Perillaldehyde) on Zebrafish Embryos and Human Umbilical Vein Endothelial Cells |
2021-12-01 |
10.2147/dddt.s336826 |
Zhou Fei, Dai Ou, Peng Cheng, Xiong Liang, Ao Hui, Liu Fei, Zhou Qin-Mei |
778515 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Establishment of Sunitinib-Resistant Xenograft Model of Renal Cell Carcinoma and the Identification of Drug-Resistant Hub Genes and Pathways |
2021-12-01 |
10.2147/dddt.s343718 |
Xie Yingwei, Shangguan Wentai, Chen Zhiliang, Zheng Zaosong, Chen Yuqing, Zhong Qiyu, Zhang Yishan, Yang Jingying, Zhu Dingjun, Xie Wenlian |
778514 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1 |
2021-12-01 |
10.2147/dddt.s323077 |
Bourafai-Aziez Asma, Benabderrahmane Mohammed, Paysant Hippolyte, Weiswald Louis-Bastien, Poulain Laurent, Carlier Ludovic, Ravault Delphine, Jouanne Marie, Coadou Gaël, Oulyadi Hassan, Voisin-Chiret Anne-Sophie, Sopková-de Oliveira Santos Jana, Sebban Muriel |
778513 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Bio-Guided Isolation of Two New Hypoglycemic Triterpenoid Saponins from Polygonum capitatum |
2021-12-01 |
10.2147/dddt.s341354 |
Huang Doudou, Du Zenan, Chen Yanhong, Dong Zhiying, Wang Xiujuan, Li Mengshuang, Zhang Feng, Chen Wansheng, Sun Lianna |
778512 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Downregulation of IRF2 Alleviates Sepsis-Related Acute Kidney Injury in vitro and in vivo |
2021-12-01 |
10.2147/dddt.s334518 |
Zhang Yanyan, Zhang Yun, Yang Aixiang, Xia Fei |
778511 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Simultaneous Determination of Loratadine and Its Metabolite Desloratadine in Beagle Plasma by LC-MS/MS and Application for Pharmacokinetics Study of Loratadine Tablets and Omeprazole‑Induced Drug–Drug Interaction |
2021-12-01 |
10.2147/dddt.s328106 |
Zhang Yu, Zhang Jiaming, Xu Qiuchi, Wang Yimeng, Wu Wenying, Wang Weiping, Li Xiaoting, Zhang Tianhong |
778510 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Comparative Pharmacokinetics/Pharmacodynamics of Fixed-Dose Combination of Esomeprazole and Calcium Carbonate (AD-206) to the Conventional Esomeprazole |
2021-12-01 |
10.2147/dddt.s341271 |
Bae Sungyeun, Kwon Jihoon, Lee Si-Beum, Jang In-Jin, Yu Kyung-Sang, Lee SeungHwan |
778509 |
DRUG DESIGN, DEVELOPMENT AND THERAPY |
Val109Asp Polymorphism of the Omentin-1 Gene and Incidence of Knee Osteoarthritis in a Chinese Han Population: A Correlation Analysis |
2021-12-01 |
10.2147/dddt.s340410 |
Chen Ruofei, Zhang Yaqin, Xu Honggang, Hu Huaqing, Chen Mingwei, Shuai Zongwen |